Menu

Image of the Day: Infrared Tumors

A camera inspired by butterfly eyes allows surgeons to see cancer cells during surgery.

Apr 18, 2018
The Scientist Staff, The Scientist Staff

Real-time imaging of tumors in a mouse after the skin has been removed and all tumors are visible.VIKTOR GRUEV

Taking a page from butterfly eyes, scientists have designed a camera that can view the world in both color and near infrared. Under the near-infrared view, cancer cells labeled with a fluorescent dye are visible to the viewer, and should help clinicians see and remove cancer cells during surgery. The research team reported their findings earlier this month (April 5) in Optica.

“Instead of putting together commercially available optics and sensors to build a camera for image-guided surgery, we looked to nature's visual systems for inspiration," says coauthor Viktor Gruev, an electrical engineer at the University of Illinois at Urbana-Champaign, in a statement. “The morpho butterfly, whose eyes contain nanostructures that sense multispectral information, can acquire both near-infrared and color information simultaneously.” 

M. Garcia et al., “Bio-inspired imager improves sensitivity in near-infrared fluorescence image-guided surgery,” Optica, doi:10.1364/OPTICA.5.000413, 2018.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!